Gylus Pharmaceuticals Private Limited

Gylus Pharmaceuticals Private Limited - trading in Hamirpur, Himachal Pradesh, India. FY 2026 financials & compliance.
CIN U24304HP2016PTC006378 Incorporated 24 October 2016 ROC Himachal Pradesh HQ Hamirpur, Himachal Pradesh, India
Active Private Limited Company trading
Revenue · FY 2023
₹66.91 Lakh
▲ 29% YoY
Net loss · FY 2023
₹6.01 Lakh
Net margin -9%
EBITDA · FY 2023
-₹4.99 Lakh
EBITDA margin -7.5%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Gylus Pharmaceuticals Private Limited

Data last updated:

Gylus Pharmaceuticals Private Limited is a private limited company based in Hamirpur, Himachal Pradesh, India. It operates in the retail trading segment of the trading and commerce sector. It was incorporated on 24 October 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24304HP2016PTC006378. Its GSTIN is 02AAGCG5720N1ZM (Himachal Pradesh).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anoop Singh Lohiya and Naresh Kumar.

Its last annual general meeting (AGM) was held on 11 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Near Old Thakur Nursing Home Barsar, Hamirpur, Himachal Pradesh, India – 174305.

As per the financials filed for FY 2023, the company reported a revenue of ₹66.91 Lakh, a growth of 29% compared to the previous year. For the same year it recorded a net loss of ₹6.01 Lakh (net margin -9%) and EBITDA of -₹4.99 Lakh (EBITDA margin -7.5%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 30% over five years.

Court records list 3 cases involving the company, including 3 filed against it; 2 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24304HP2016PTC006378
Registration Number 006378
Incorporation Date 24 October 2016
ROC Himachal Pradesh
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Gylus Pharmaceuticals Private Limited's registered office is in Hamirpur, Himachal Pradesh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Near Old Thakur Nursing Home Barsar, Hamirpur, Himachal Pradesh, India – 174305
  • Industry
    Trading, Retail Trading, Retailers

To see the full contact details of Gylus Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Gylus Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Gylus Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Gylus Pharmaceuticals Private Limited, buy the company report.

Financials of Gylus Pharmaceuticals Private Limited

FY 2023 filings available

Gylus Pharmaceuticals Private Limited reported revenue of ₹66.91 Lakh (up 29% YoY) for FY 2023.

Revenue · FY 2023
₹66.91 Lakh ▲ 29%
Net loss · FY 2023
₹6.01 Lakh margin -9%
EBITDA · FY 2023
-₹4.99 Lakh margin -7.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 29%
3 years · compounded
▲ 3%
5 years · compounded
▲ 30%
EBITDA CAGR growth
1 year
▲ 25%
3 years · compounded
▼ 53%
5 years · compounded
▼ 15%

Revenue has grown at a compounded annual rate (CAGR) of 30% over five years, including 29% growth in the latest year. EBITDA rose 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹4.99 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹6.01 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin-7.5%
Net Profit Margin-9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Gylus Pharmaceuticals Private Limited, buy the company report.

Board of directors of Gylus Pharmaceuticals Private Limited

Gylus Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Anoop Singh LohiyaDirector24 Oct 201610 Years 0 MonthsCurrent
Naresh KumarDirector24 Oct 201610 Years 0 MonthsCurrent

Peer comparison

Gylus Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Waxemon Pharmaceuticals (OPC) Private Limited₹67.52 Lakh (FY 2025)2.0%Lucknow, Uttar Pradesh, India
Seramic Pharmaceuticals Private Limited₹67.42 Lakh (FY 2025)-49.0%Bhiwandi, Maharashtra, India
Jigson Pharmaceuticals Private Limited₹67.17 Lakh (FY 2025)4.0%Ahmedabad, Gujarat, India
Gylus Pharmaceuticals Private Limitedthis company₹66.91 Lakh (FY 2023)-₹6.01 Lakh-9%29.0%Hamirpur, Himachal Pradesh, India
Rcsat Pharmaceuticals Private Limited₹66.71 Lakh (FY 2025)-38.0%Meerut, Uttar Pradesh, India
Equinox Pharmaceuticals Private Limited₹66.64 Lakh (FY 2025)27.0%Patna, Bihar, India

To see the full peer comparison of Gylus Pharmaceuticals Private Limited, buy the company report.

Auditor

Gylus Pharmaceuticals Private Limited is audited by Rajesh Sharma & Associates for the financial year 2017.

Auditor firmFinancial yearFirm registration number
Rajesh Sharma & AssociatesFY 2017538641

Shareholding

The shareholding of Gylus Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Gylus Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Gylus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Gylus Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
02AAGCG5720N1ZMHimachal PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Gylus Pharmaceuticals Private Limited, buy the company report.

Recent activity

Gylus Pharmaceuticals Private Limited has 5 board changes on record since 2016: 2 appointments and 3 cessations. The latest: Prince Kumar ceased to be Director on 03 Jul 2024.

Ceased
Prince Kumar ceased to be Director.
AGM
Gylus Pharmaceuticals Private Limited last Annual general meeting of members was held on 11 Sep 2023 as per latest MCA records.
Filing
Gylus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Himachal Pradesh.
Ceased
Mukesh Kumar ceased to be Director.
Ceased
Samridhi Minhas ceased to be Director.
Appointed
Anoop Singh Lohiya was appointed as Director.
Appointed
Naresh Kumar was appointed as Director.
Incorporation
24 Oct 2016
Gylus Pharmaceuticals Private Limited was registered on 24 Oct 2016 with Roc Himachal Pradesh & aged 10 years 28 days as per MCA records.

Frequently asked questions

Gylus Pharmaceuticals is an active private limited company based in Hamirpur, Himachal Pradesh, India. The company works in retail trading, within the trading industry. It was incorporated on 24 October 2016 (10+ years old) and is registered under CIN U24304HP2016PTC006378.

Gylus Pharmaceuticals has 2 current directors:

The latest financial statements of Gylus Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 11 September 2023. Year-wise statements from FY 2017 are in the company report.

The GSTIN of Gylus Pharmaceuticals is 02AAGCG5720N1ZM, registered in Himachal Pradesh.

The CIN (Corporate Identification Number) of Gylus Pharmaceuticals is U24304HP2016PTC006378. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Gylus Pharmaceuticals has 3 court cases on record: 3 filed against it. 2 are pending.

Gylus Pharmaceuticals was incorporated on 24 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.

The peers of Gylus Pharmaceuticals by revenue are Waxemon Pharmaceuticals (OPC) Private Limited, Seramic Pharmaceuticals Private Limited, Jigson Pharmaceuticals Private Limited, Rcsat Pharmaceuticals Private Limited, Equinox Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Prince Kumar ceased to be Director on 03 Jul 2024. Mukesh Kumar ceased to be Director on 09 Nov 2018. Samridhi Minhas ceased to be Director on 27 Mar 2018. Gylus Pharmaceuticals has 5 board changes on record in total.

The registered office of Gylus Pharmaceuticals is at Near Old Thakur Nursing Home Barsar, Hamirpur, Himachal Pradesh, India – 174305.

Gylus Pharmaceuticals operates in the trading industry, in the retail trading segment.